Named on one round in the feed.
Since 2026-10-07
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Matchpoint Therapeutics A biotechnology company pioneering the discovery of precision covalent medicines | Series B Verified against 1 of 6 sources | $150M | 2026-10-07 | [ PART ] |